Predicted protein targets (top 14)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | HDAC4 | P56524 | 1/20 | 0.46 |
| ▸ | HDAC7 | Q8WUI4 | 1/20 | 0.46 |
| ▸ | HDAC5 | Q9UQL6 | 1/20 | 0.46 |
| ▸ | CES2 | O00748 | 2/20 | 0.45 |
| ▸ | CES1 | P23141 | 2/20 | 0.45 |
| ▸ | CNR2 | P34972 | 1/20 | 0.42 |
| ▸ | PGR | P06401 | 1/20 | 0.40 |
| ▸ | AR | P10275 | 1/20 | 0.40 |
| ▸ | EPHX1 | P07099 | 1/20 | 0.40 |
| ▸ | CNR1 | P21554 | 1/20 | 0.40 |
| ▸ | FBP1 | P09467 | 2/20 | 0.40 |
| ▸ | IDO1 | P14902 | 1/20 | 0.39 |
| ▸ | TDO2 | P48775 | 1/20 | 0.39 |
| ▸ | MTOR | P42345 | 1/20 | 0.38 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL28005114 | 0.81 | HDAC4 (0.45) | HDAC4HDAC7HDAC5CES2CES1 | |
| SCHEMBL6106703 | 0.80 | ACP3 (0.45) | EPHX1CNR1FBP1 | |
| SCHEMBL6100121 | 0.80 | MEN1 (0.47) | CNR1FBP1 | |
| SCHEMBL74691 | 0.80 | SRC (0.48) | CES2CES1 | |
| SCHEMBL27810151 | 0.79 | HDAC3 (0.40) | HDAC4HDAC7HDAC5CES2CES1 | |
| SCHEMBL11602886 | 0.78 | SRC (0.46) | CES2CES1 | |
| SCHEMBL887039 | 0.78 | SRC (0.46) | CES2CES1 | |
| SCHEMBL11602507 | 0.78 | SRC (0.46) | CES2CES1 | |
| SCHEMBL27814338 | 0.78 | PTGS1 (0.58) | — | |
| SCHEMBL3711116 | 0.74 | SRC (0.58) | HDAC4HDAC7HDAC5CES2CES1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 7 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-104447347-A | Preparation method for sunitinibmalate intermediate | PARLING SHANGHAI PHARMATECH CO LTD | 2015-03-25 | — | — | CN | claimed |
| WO-2026098560-A2 | BENZENE-CONTAINING POLYCYCLIC DERIVATIVE MODULATOR, PREPARATION METHOD THEREFOR AND USE THEREOF | 上海翰森生物医药科技有限公司 | 2026-05-15 | — | — | WO | disclosed |
| CN-110551103-B | JAK3 selective inhibitor | 北京大学深圳研究生院 | 2022-08-23 | — | — | CN | disclosed |
| CN-110551103-A | JAK3 selective inhibitor | SHENZHEN GRADUATE SCHOOL PEKING UNIV | 2019-12-10 | — | — | CN | disclosed |
| CN-104447347-A | Preparation method for sunitinibmalate intermediate | PARLING SHANGHAI PHARMATECH CO LTD | 2015-03-25 | — | — | CN | disclosed |
| CN-104447347-A | Preparation method for sunitinibmalate intermediate | PARLING SHANGHAI PHARMATECH CO LTD | 2015-03-25 | — | — | CN | disclosed |
| US-4160032-A | Oxindoles as sleep-inducers | SANDOZ, INC. (US) | 1979-07-03 | — | — | US | disclosed |